Syngene International, 539268, SYNGENE Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

23,116.00
65.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

23,520.10
N/A
9.39

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

20.11
12.69
12.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.07
9.62
9.09

PAT CAGR (%)

10 Years
5 Years
3 Years

30.69
11.31
10.50

P:E (Median)

8 Years
5 Years
3 Years

-
35.78
37.11

P:BV (Average)

8 Years
5 Years
3 Years

-
5.05
6.83

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
16.28
22.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 517.00 464.60 11.28% 420.20 420.90 -0.17% 607.30 533.90 13.75% 519.10 467.10 11.13%
Expenses 368.80 328.90 12.13% 296.00 299.90 -1.30% 403.60 374.30 7.83% 376.20 327.20 14.98%
EBITDA 148.20 135.70 9.21% 124.20 121.00 2.64% 203.70 159.60 27.63% 142.90 139.90 2.14%
EBIDTM 28.67% 29.21% 29.56% 28.75% -0.29% -0.29% 27.53% 29.95%
Other Income 20.60 23.80 -13.45% 15.30 20.50 -25.37% 20.50 20.80 -1.44% 30.20 17.70 70.62%
Interest 6.60 8.40 -21.43% 7.40 7.10 4.23% 9.30 8.00 16.25% 9.80 8.20 19.51%
Depreciation 68.70 52.60 30.61% 66.10 47.40 39.45% 62.30 44.10 41.27% 57.00 42.90 32.87%
PBT 93.50 169.80 -44.94% 66.00 87.00 -24.14% 152.60 128.30 18.94% 106.30 106.50 -0.19%
Tax 9.90 41.80 -76.32% 8.20 15.10 -45.70% 32.60 28.50 14.39% 14.70 19.80 -25.76%
PAT 83.60 128.00 -34.69% 57.80 71.90 -19.61% 120.00 99.80 20.24% 91.60 86.70 5.65%
PATM 16.17% 27.55% 13.76% 17.08% 2.87% 2.87% 17.65% 18.56%
EPS 2.09 3.20 -34.69% 1.44 1.80 -20.00% 3.00 2.50 20.00% 2.29 2.17 5.53%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 519.60 464.60 11.84% 421.60 420.90 0.17% 607.30 533.90 13.75% 519.10 467.10 11.13%
Expenses 370.70 328.60 12.81% 297.10 299.80 -0.90% 403.20 373.90 7.84% 375.80 326.90 14.96%
EBITDA 148.90 136.00 9.49% 124.50 121.10 2.81% 204.10 160.00 27.56% 143.30 140.20 2.21%
EBIDTM 28.66% 29.27% 29.53% 28.77% 14.01% 14.01% 27.61% 30.02%
Other Income 20.60 23.80 -13.45% 15.30 20.50 -25.37% 20.50 20.80 -1.44% 30.20 17.70 70.62%
Interest 6.60 8.40 -21.43% 7.40 7.10 4.23% 9.30 8.00 16.25% 9.80 8.20 19.51%
Depreciation 68.70 52.60 30.61% 66.10 47.40 39.45% 62.30 44.10 41.27% 57.00 42.90 32.87%
PBT 94.20 170.10 -44.62% 66.30 87.10 -23.88% 153.00 128.70 18.88% 106.70 106.80 -0.09%
Tax 10.10 42.00 -75.95% 8.30 15.10 -45.03% 32.80 28.60 14.69% 14.90 19.80 -24.75%
PAT 84.10 128.10 -34.35% 58.00 72.00 -19.44% 120.20 100.10 20.08% 91.80 87.00 5.52%
PATM 16.19% 27.57% 13.76% 17.11% 7.11% 7.11% 17.68% 18.63%
EPS 2.10 3.20 -34.38% 1.45 1.80 -19.44% 3.00 2.50 20.00% 2.29 2.17 5.53%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 2,063.60 2,011.90 1,825.60 1,423.10 1,200.90 1,107.00 859.90 699.50 550.00 416.70 321.90 Net Sales Growth 9.39% 10.20% 28.28% 18.50% 8.48% 28.74% 22.93% 27.18% 31.99% 29.45% Cost Of Goods Sold 861.02 519.40 531.30 381.70 321.80 310.40 239.00 191.40 150.10 111.10 87.60 Gross Profit 1,202.58 1,492.50 1,294.30 1,041.40 879.10 796.60 620.90 508.10 399.90 305.60 234.30 GP Margin 58.28% 74.18% 70.90% 73.18% 73.20% 71.96% 72.21% 72.64% 72.71% 73.34% 72.79% Total Expenditure 1,444.60 1,409.70 1,291.10 1,033.00 816.20 726.60 578.80 486.00 386.00 277.80 216.80 Power & Fuel Cost - 45.80 41.30 34.70 30.40 30.80 27.50 23.40 21.20 19.60 18.60 % Of Sales - 2.28% 2.26% 2.44% 2.53% 2.78% 3.20% 3.35% 3.85% 4.70% 5.78% Employee Cost - 572.20 465.40 376.90 308.60 249.30 201.90 155.60 123.50 98.40 80.00 % Of Sales - 28.44% 25.49% 26.48% 25.70% 22.52% 23.48% 22.24% 22.45% 23.61% 24.85% Manufacturing Exp. - 103.70 85.70 66.70 55.50 29.50 21.40 15.80 7.90 6.30 5.50 % Of Sales - 5.15% 4.69% 4.69% 4.62% 2.66% 2.49% 2.26% 1.44% 1.51% 1.71% General & Admin Exp. - 140.60 146.00 142.40 83.40 64.80 54.30 41.30 23.10 16.70 11.90 % Of Sales - 6.99% 8.00% 10.01% 6.94% 5.85% 6.31% 5.90% 4.20% 4.01% 3.70% Selling & Distn. Exp. - 11.10 7.70 6.10 6.30 4.80 3.80 2.60 3.00 2.40 2.20 % Of Sales - 0.55% 0.42% 0.43% 0.52% 0.43% 0.44% 0.37% 0.55% 0.58% 0.68% Miscellaneous Exp. - 16.90 13.70 24.50 10.20 37.00 30.90 55.90 57.20 23.30 2.20 % Of Sales - 0.84% 0.75% 1.72% 0.85% 3.34% 3.59% 7.99% 10.40% 5.59% 3.42% EBITDA 619.00 602.20 534.50 390.10 384.70 380.40 281.10 213.50 164.00 138.90 105.10 EBITDA Margin 30.00% 29.93% 29.28% 27.41% 32.03% 34.36% 32.69% 30.52% 29.82% 33.33% 32.65% Other Income 86.60 96.10 76.20 136.10 93.60 6.30 11.70 8.20 4.20 1.50 1.00 Interest 33.10 34.60 32.30 22.70 17.50 8.40 7.90 0.40 6.50 10.30 26.60 Depreciation 254.10 219.30 164.20 131.40 114.30 97.30 81.40 65.60 59.90 54.70 50.90 PBT 418.40 444.40 414.20 372.10 346.50 281.00 203.50 155.70 101.80 75.40 28.60 Tax 65.40 104.20 83.50 67.00 59.20 40.20 28.50 21.80 4.20 2.70 0.30 Tax Rate 15.63% 20.21% 20.16% 18.01% 17.09% 14.31% 14.00% 14.00% 4.13% 3.58% 1.05% PAT 353.00 411.50 330.70 305.10 287.30 240.80 175.00 133.90 97.60 72.70 28.30 PAT before Minority Interest 353.00 411.50 330.70 305.10 287.30 240.80 175.00 133.90 97.60 72.70 28.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.11% 20.45% 18.11% 21.44% 23.92% 21.75% 20.35% 19.14% 17.75% 17.45% 8.79% PAT Growth -8.64% 24.43% 8.39% 6.20% 19.31% 37.60% 30.69% 37.19% 34.25% 156.89% EPS 8.83 10.29 8.27 7.63 7.18 6.02 4.38 3.35 2.44 1.82 0.71

Description TTM Mar 20 Mar 19 Mar 18
Net Sales 2,067.60 2,011.90 1,825.60 1,423.10 Net Sales Growth 9.60% 10.20% 28.28% Cost Of Goods Sold 5,006.00 519.40 531.30 381.70 Gross Profit -2,938.40 1,492.50 1,294.30 1,041.40 GP Margin -142.12% 74.18% 70.90% 73.18% Total Expenditure 1,446.80 1,408.50 1,289.90 1,032.60 Power & Fuel Cost - 45.80 41.30 34.70 % Of Sales - 2.28% 2.26% 2.44% Employee Cost - 580.40 472.70 379.60 % Of Sales - 28.85% 25.89% 26.67% Manufacturing Exp. - 103.70 85.70 66.70 % Of Sales - 5.15% 4.69% 4.69% General & Admin Exp. - 131.60 137.40 139.30 % Of Sales - 6.54% 7.53% 9.79% Selling & Distn. Exp. - 11.10 7.70 6.10 % Of Sales - 0.55% 0.42% 0.43% Miscellaneous Exp. - 16.50 13.80 24.50 % Of Sales - 0.82% 0.76% 1.72% EBITDA 620.80 603.40 535.70 390.50 EBITDA Margin 30.03% 29.99% 29.34% 27.44% Other Income 86.60 96.10 76.20 136.10 Interest 33.10 34.60 32.30 22.70 Depreciation 254.10 219.30 164.20 131.40 PBT 420.20 445.60 415.40 372.50 Tax 66.10 104.80 83.80 67.10 Tax Rate 15.73% 20.27% 20.17% 18.01% PAT 354.10 412.10 331.60 305.40 PAT before Minority Interest 354.10 412.10 331.60 305.40 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 17.13% 20.48% 18.16% 21.46% PAT Growth -8.55% 24.28% 8.58% EPS 8.85 10.30 8.29 7.64

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 2,174.10 1,967.20 1,720.10 1,413.10 1,024.70 844.90 659.30 519.60 302.20 224.50 Share Capital 400.00 200.00 200.00 200.00 200.00 199.10 26.10 26.20 24.10 2.90 Total Reserves 1,735.20 1,739.20 1,491.90 1,187.90 805.80 633.90 627.30 493.40 278.10 221.60 Non-Current Liabilities 325.20 515.00 612.60 697.70 725.10 101.40 69.20 55.70 69.00 50.00 Secured Loans 0.00 346.60 568.80 689.80 725.20 18.60 0.00 0.00 4.20 0.00 Unsecured Loans 0.00 0.00 16.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 40.90 37.40 29.00 19.90 18.10 13.20 5.80 2.80 1.20 1.20 Current Liabilities 1,540.00 1,128.60 783.30 600.30 534.00 475.20 462.40 148.90 220.30 233.30 Trade Payables 222.80 223.50 203.40 102.50 74.40 69.20 76.60 82.60 64.40 28.00 Other Current Liabilities 955.10 677.60 475.60 379.40 276.40 260.20 221.20 57.50 56.60 56.50 Short Term Borrowings 308.90 190.70 78.10 97.20 165.80 136.40 154.90 0.00 92.60 145.00 Short Term Provisions 53.20 36.80 26.20 21.20 17.40 9.40 9.70 8.80 6.70 3.80 Total Liabilities 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80 1,421.50 1,190.90 724.20 591.50 507.80 Net Block 1,983.70 1,336.80 1,030.40 810.40 580.20 503.30 394.10 381.00 383.00 387.60 Gross Block 2,967.40 2,121.20 1,660.70 1,331.90 1,111.40 938.00 719.90 643.80 586.00 535.90 Accumulated Depreciation 983.70 784.40 630.30 521.50 531.20 434.70 325.80 262.80 203.00 148.30 Non Current Assets 2,427.90 1,848.20 1,396.70 1,187.00 949.10 835.70 556.90 487.20 448.70 427.70 Capital Work in Progress 234.10 273.70 155.40 174.90 236.80 105.10 45.30 8.80 10.80 0.90 Non Current Investment 74.30 40.30 0.30 0.00 0.00 0.00 0.10 0.10 0.10 0.00 Long Term Loans & Adv. 107.80 121.90 94.90 91.20 71.70 113.40 102.90 86.20 49.70 39.10 Other Non Current Assets 28.00 75.50 115.70 110.50 60.40 113.90 14.50 11.10 5.10 0.10 Current Assets 1,611.40 1,762.60 1,719.30 1,524.10 1,334.70 585.80 634.00 237.00 142.80 80.10 Current Investments 738.40 716.00 157.70 540.40 276.60 146.00 352.00 69.10 0.00 2.60 Inventories 25.20 43.40 86.00 32.20 37.70 38.40 14.90 17.90 19.80 10.00 Sundry Debtors 398.20 338.70 266.80 198.70 185.20 179.90 94.30 76.60 43.40 38.40 Cash & Bank 280.30 435.40 966.50 527.30 719.90 115.70 91.60 11.80 37.70 5.90 Other Current Assets 169.30 225.20 236.40 201.60 115.30 105.80 81.20 61.60 41.90 23.20 Short Term Loans & Adv. 17.80 3.90 5.90 23.90 25.10 28.90 24.90 11.30 4.10 3.60 Net Current Assets 71.40 634.00 936.00 923.80 800.70 110.60 171.60 88.10 -77.50 -153.20 Total Assets 4,039.30 3,610.80 3,116.00 2,711.10 2,283.80 1,421.50 1,190.90 724.20 591.50 507.80

Description Mar 20 Mar 19 Mar 18
Shareholder's Funds 2,175.80 1,968.40 1,720.40 Share Capital 400.00 200.00 200.00 Total Reserves 1,736.90 1,740.40 1,492.20 Non-Current Liabilities 325.20 515.00 612.60 Secured Loans 0.00 346.60 568.80 Unsecured Loans 0.00 0.00 16.70 Long Term Provisions 40.90 37.40 29.00 Current Liabilities 1,539.20 1,128.60 783.60 Trade Payables 222.00 223.50 203.50 Other Current Liabilities 955.10 677.60 475.70 Short Term Borrowings 308.90 190.70 78.10 Short Term Provisions 53.20 36.80 26.30 Total Liabilities 4,040.20 3,612.00 3,116.60 Net Block 1,983.70 1,336.80 1,030.40 Gross Block 2,967.40 2,121.20 1,660.70 Accumulated Depreciation 983.70 784.40 630.30 Non Current Assets 2,427.60 1,847.90 1,396.40 Capital Work in Progress 234.10 273.70 155.40 Non Current Investment 74.00 40.00 0.00 Long Term Loans & Adv. 107.80 121.90 94.90 Other Non Current Assets 28.00 75.50 115.70 Current Assets 1,612.60 1,764.10 1,720.20 Current Investments 738.40 716.00 157.70 Inventories 25.20 43.40 86.00 Sundry Debtors 398.20 338.70 266.80 Cash & Bank 281.50 436.90 967.40 Other Current Assets 169.30 225.20 236.40 Short Term Loans & Adv. 17.80 3.90 5.90 Net Current Assets 73.40 635.50 936.60 Total Assets 4,040.20 3,612.00 3,116.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 677.40 629.80 445.60 398.10 308.10 18.50 299.50 110.60 129.30 80.90 PBT 411.50 330.70 305.10 287.30 240.80 203.50 155.70 101.80 75.40 28.60 Adjustment 327.40 212.50 248.10 148.40 132.90 72.90 48.60 62.10 61.90 71.20 Changes in Working Capital 44.90 182.30 -26.80 36.90 -25.50 -215.80 130.10 -33.70 4.40 -12.80 Cash after chg. in Working capital 783.80 725.50 526.40 472.60 348.20 60.60 334.40 130.20 141.70 87.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -106.40 -95.70 -80.80 -74.50 -40.10 -42.10 -34.90 -19.60 -12.40 -6.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -428.40 -646.50 -349.60 -469.10 -751.20 12.00 -374.20 -157.30 -29.60 -19.50 Net Fixed Assets -806.60 -578.80 -309.30 -158.60 -305.10 -277.90 -112.60 -55.80 -60.00 -22.36 Net Investments -56.40 -598.30 382.40 -263.80 -130.60 206.10 -282.90 -69.10 2.50 8.27 Others 434.60 530.60 -422.70 -46.70 -315.50 83.80 21.30 -32.40 27.90 -5.41 Cash from Financing Activity -225.50 -72.40 -78.70 -81.20 716.10 -10.10 155.40 20.70 -69.90 -62.10 Net Cash Inflow / Outflow 23.50 -89.10 17.30 -152.20 273.00 20.40 80.70 -26.00 29.80 -0.70 Opening Cash & Equivalents 163.70 251.80 234.50 387.30 115.70 91.60 11.80 37.70 5.90 6.60 Closing Cash & Equivalent 191.80 163.70 251.80 234.50 387.30 115.70 91.60 11.80 37.70 5.90

Description Mar 20 Mar 19 Mar 18
Cash From Operating Activity 677.10 630.40 446.20 PBT 412.10 331.60 305.40 Adjustment 328.00 212.80 248.20 Changes in Working Capital 44.10 182.10 -26.60 Cash after chg. in Working capital 784.20 726.50 527.00 Interest Paid 0.00 0.00 0.00 Tax Paid -107.10 -96.10 -80.80 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -428.40 -646.50 -349.30 Net Fixed Assets -806.60 -578.80 Net Investments -56.40 -598.30 Others 434.60 530.60 Cash from Financing Activity -225.50 -72.40 -78.70 Net Cash Inflow / Outflow 23.20 -88.50 18.20 Opening Cash & Equivalents 165.20 252.70 234.50 Closing Cash & Equivalent 193.00 165.20 252.70

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 53.38 48.48 42.30 34.70 25.14 20.92 17.63 13.97 8.84 6.62 ROA 10.76% 9.83% 10.47% 11.50% 13.00% 13.40% 13.98% 14.84% 13.23% 5.54% ROE 20.20% 18.21% 19.81% 24.00% 26.19% 23.55% 22.83% 23.75% 27.61% 13.46% ROCE 19.57% 16.94% 16.70% 17.60% 19.85% 23.31% 23.33% 23.46% 21.89% 14.14% Fixed Asset Turnover 0.79 0.97 0.95 0.98 1.08 1.04 1.03 0.89 0.74 0.62 Receivable days 66.84 60.53 59.70 58.34 60.19 58.19 44.59 39.82 35.83 40.34 Inventory Days 6.22 12.94 15.16 10.62 12.55 11.31 8.56 12.51 13.05 12.40 Payable days 54.64 59.61 54.99 38.31 36.00 45.79 63.69 73.12 57.44 55.40 Cash Conversion Cycle 18.42 13.85 19.87 30.65 36.74 23.72 -10.54 -20.79 -8.56 -2.66 Total Debt/Equity 0.32 0.41 0.47 0.58 0.89 0.19 0.24 0.01 0.32 0.71 Interest Cover 15.90 13.82 17.39 20.80 34.45 26.76 390.25 16.66 8.32 2.08

Description Mar 20 Mar 19 Mar 18
Book Value (Rs.) 53.42 48.51 42.30 ROA 10.77% 9.86% 9.80% ROE 20.21% 18.26% 18.05% ROCE 19.60% 16.98% 15.76% Fixed Asset Turnover 0.79 0.97 0.86 Receivable days 66.84 60.53 68.43 Inventory Days 6.22 12.94 22.06 Payable days 54.25 59.30 72.96 Cash Conversion Cycle 18.82 14.17 17.52 Total Debt/Equity 0.32 0.41 0.47 Interest Cover 15.94 13.86 17.41

Top Investors:

camas investments pte. ltd.

uti-unit linked insurance plan

qualified institutional buyer

Annual Reports:

News Update:

Syngene International inks pact with Deerfield Discovery and Development Corporation
20th Nov 2020, 09:04 AM

The agreement aims to collaborate to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation
Read More
Syngene International, HiMedia get ICMR’s nod for COVID-19 antibody test kit ‘ELISafe 19’
10th Sep 2020, 11:55 AM

The ELISafe 19 antibody test kit has a sensitivity of 100% and specificity of 99%
Read More

Syngene International Ltd.

Pharmaceuticals & Drugs - Global

BSE: 539268 | NSE: SYNGENE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Syngene International Ltd.

Pharmaceuticals & Drugs - Global

BSE: 539268 | NSE: SYNGENE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: